Impact of Donor Type on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Juan Carlos Hernandez Boluda, Vipul Sharad Sheth, Simona Iacobelli, Linda Koster, Nicolaus Kröger, Simona Sica, Thomas Schroeder, Regis Peffault De Latour, Emanuele Angelucci, Didier Blaise, Henrik Sengeloev, Jakob Passweg, Matthias Stelljes, Robert Zeiser, Ibrahim Yakoub-Agha, Andrew Clark, Urpu Salmenniemi, Piero Galieni, Werner Rabitsch, Kavita K Raj, Joanna Drozd-Sokolowska, Marie Robin, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Donal P McLornan
Institutions: Hospital Clínico Universitario de Valencia, Rajiv Gandhi Cancer Institute and Research Centre, University of Rome Tor Vergata, European Society for Blood and Marrow Transplantation, Università Cattolica del Sacro Cuore, Essen University Hospital, Hôpital Saint-Louis, Ospedale Policlinico San Martino, Institut Paoli-Calmettes, Rigshospitalet, University Hospital of Basel, University of Münster, University Hospital Münster, University of Freiburg, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Institute for Translational Research in Inflammation, University of Helsinki, Helsinki University Hospital, Medical University of Vienna, University College London Hospitals NHS Foundation Trust, University College London, Medical University of Warsaw, Central Clinical Hospital, Assistance Publique – Hôpitaux de Paris, Federico II University Hospital, University of Naples Federico II, Policlinico San Matteo Fondazione, The Maria Sklodowska-Curie National Research Institute of Oncology
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405034613